• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 04, 2022 at 10:52: PM
via Indian drugmaker Dr Reddy's Laboratories Ltd (REDY.NS) will launch its generic version of Merck's (MRK.N) antiviral COVID-19 pill, molnupiravir, and price it at 35 rupees ($0.4693) per capsule, a company spokesperson said on Tuesday.

article source
 

<



Similar threads

cafead
Haleon reels in $633M with sale of ex-US nicotine replacement unit to Dr. Reddy&#039;s
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
India&#039;s Dr Reddy&#039;s expects healthy products pipeline in North America for FY25
Replies
0
Views
61
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Dr. Reddy&#039;s to buy Mayne Pharma’s US generics drug list for at least $90M
Replies
0
Views
77
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy&#039;s
Replies
0
Views
122
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Dr. Reddy&#039;s subsidiary hits the pause button on drug development for psoriasis
Replies
0
Views
183
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote